# About Epitalon Compound: An Independent Editorial Digest

> About Epitalon Compound — an independent editorial project that summarizes the peer-reviewed research on Epitalon. Not a clinic, not a vendor, no medical advice.

Who publishes this, what it is, and — just as important — what it is not.

## What this site is

Epitalon Compound is an independent editorial project that publishes summaries of the peer-reviewed research literature on Epitalon, the synthetic AEDG tetrapeptide. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science — a careful reading of what the studies measured, organized so a non-specialist can follow it without losing the technical detail underneath.

## What the name means

The "compound" in Epitalon Compound is editorial framing, not a claim about services. It signals that this is a research-literature publication concerned with a specific chemical compound — its mechanisms, its studies, its open questions — rather than a storefront or a treatment service. We occupy a position relative to the literature: that of an attentive reader who weighs claims against evidence. We do not occupy any position relative to your health. Nothing here is a prescription, a consultation, or an endorsement of using the compound.

## How we handle the evidence

Our editorial stance on Epitalon is set by the shape of its evidence base. The findings are real and specific, but they originate overwhelmingly from a single research lineage and rest on animal and cell work plus uncontrolled human observation. We therefore present preclinical results as preclinical, claims as claims, and we foreground the single-laboratory attribution and the investigational, unapproved status of the compound on every page. We cite every quantitative statement to a primary source, we distinguish Epitalon from its parent extract epithalamin, and we give no human dosing. When the evidence is strong we say so plainly; when it is thin we say that too.

## Corrections and accuracy

This is a digest of a living literature, and the literature on Epitalon is actively changing — the most important recent additions, an independent replication and a systematic review, both arrived in 2025. We update as new peer-reviewed work appears, and we aim to represent each study as its authors framed it, including its limitations. If a summary here misstates a finding or a citation, that is an error we want to fix. The contact page explains how to reach us about the content.

---

An editorial reading of the Epitalon literature, set in type against the evidence — not a clinic, not a vendor, and not a prescription.